Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02417038 · ClinicalTrials.gov registry record
Postoperative Respiratory Monitoring After Neuraxial Opioid Administration for Cesarean Delivery
A clinical trial of Respiratory Depression, sponsored by Stanford University.
- Completed
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT02417038 is a study of Respiratory Depression that has completed, run by Stanford University. The registered enrollment target is 80 participants, above the 31-participant average among 4 other Respiratory Depression trials with a reported enrollment target (158% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02417038, a study of Respiratory Depression, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Respiratory depression occurs in labor and delivery; noticeably when neuraxial opioids are given.Pathophysiological respiratory depression -failure to respond to hypercapnia or hypoxia - is challenging to measure clinically.American Society of Anesthesiologist guidelines recommend suitable respiratory monitoring for 24 hours post cesarean delivery (CD). Use of capnograph will enable us to assess breath-by-breathe respiration in a population receiving neuraxial opioids - potentially at risk for respiratory depression. Our aim is to assess our ability to capture maternal postpartum respiratory parameters in a cohort following opioid neuraxial administration for CD.
Conditions Studied
Interventions
- DEVICE Capnostream
Study Locations (1)
California
- Lucile Packard Children's Hospital - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-04-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02417038
The ClinicalTrials.gov registry entry for NCT02417038 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 31-participant average among 4 other Respiratory Depression trials with a reported enrollment target (158% higher). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Respiratory Depression appearing as the primary indexed condition, and to 1 intervention - of which Capnostream is the first listed.
NCT02417038 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02417038 about?
NCT02417038 is a clinical study titled "Postoperative Respiratory Monitoring After Neuraxial Opioid Administration for Cesarean Delivery". Respiratory depression occurs in labor and delivery; noticeably when neuraxial opioids are given.Pathophysiological respiratory depression -failure to respond to hypercapnia or hypoxia - is challenging to measure clinically.American Society of Anesthesiologist guidelines recommend suitable respirato...
What is the current status of trial NCT02417038?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2015-04. Estimated completion is 2016-04-15.
What conditions does trial NCT02417038 study?
This clinical trial studies the following conditions: Respiratory Depression.
What interventions are being tested in trial NCT02417038?
The interventions under investigation include: Capnostream (DEVICE).
Who is sponsoring clinical trial NCT02417038?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02417038 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ENA-001 for Opioid Induced Respiratory Depression
ACTIVE NOT RECRUITING · Phase 1
-
The Effects of Ketamine on Respiratory Stimulation and Transpulmonary Pressures
COMPLETED · NA
-
Pupillary Unrest in Ambient Light, and Relationship to Opioid-Induced Respiratory Depression
COMPLETED · Phase 1
-
Effect of Opioids on Ventilation in Children With Obstructive Sleep Apnea
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.